Citations

Mayo Clinic

Showing 10 of 108599 citations.

Comprehensive care for the child or adolescent diagnosed with a childhood malignancy requiring palliative radiation therapy: A review
Vern-Gross, T.Z.

Applied Radiation Oncology | June 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: 7-17

10.37549/aro1162 Get It

Open-Spaced Ridged Hydrogel Scaffolds Containing TiO2-Self-Assembled Monolayer of Phosphonates Promote Regeneration and Recovery Following Spinal Cord Injury
Siddiqui, Ahad M. , Thiele, Frederic, Stewart, Rachel , Rangnick, Simone, Weiss, Georgina J., Chen, Bingkun K. , Silvernail, Jodi L., Strickland, Tammy , Nesbitt, Jarred J., Lim, Kelly, Schwarzbauer, Jean E. , Yaszemski, Michael J. , Windebank, Anthony J. , Madigan, Nicolas N. , Stewart, Rachel N , Madigan, Nicolas N , Schwartz, Jeffrey

International Journal of Molecular Sciences | June 16, 2023 | Volume: 24 | Issue: 12 | Pages: 10250

10.3390/ijms241210250 | PMID 37373396 Get It

The spinal cord has a poor ability to regenerate after an injury, which may be due to cell loss, cyst formation, inflammation, and scarring. A promising approach to treating a spinal cord injury (SCI) is the use of biomaterials. We have developed a novel hydrogel scaffold fabricated from oligo(poly(ethylene glycol) fumarate) (OPF) as a 0.08 mm thick sheet containing polymer ridges and a cell-attractive surface on the other side. When the cells are cultured on OPF via chemical patterning, the cells attach, align, and deposit ECM along the direction of the pattern. Animals implanted with the rolled scaffold sheets had greater hindlimb recovery compared to that of the multichannel scaffold control, which is likely due to the greater number of axons growing across it. The immune cell number (microglia or hemopoietic cells: 50–120 cells/mm2 in all conditions), scarring (5–10% in all conditions), and ECM deposits (Laminin or Fibronectin: approximately 10–20% in all conditions) were equal in all conditions. Overall, the results suggest that the scaffold sheets promote axon outgrowth that can be guided across the scaffold, thereby promoting hindlimb recovery. This study provides a hydrogel scaffold construct that can be used in vitro for cell characterization or in vivo for future neuroprosthetics, devices, or cell and ECM delivery.
Future of Radiation Oncology Education: Transforming Scholarly Teaching Into Medical Education Scholarship
Saraf, Anurag , Boyd, Graham , Leo, Alexandra De, Gawu, Phylicia, Franco, Idalid , Singer, Lisa , Pinnix, Chelsea C. , Braunstein, Steve , Jimenez, Rachel

Applied Radiation Oncology | June 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.37549/aro1334 Get It

Personalizing Approaches to Patient Education Throughout the Radiation Oncology Workflow
Goldman, J.W., Londoño, Valeria, Hoffe, Sarah E. , Goldman, Jodi, Lin, Keldon K.

Applied Radiation Oncology | June 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.37549/aro1331 Get It

Improving Well-Being and Combating Burnout in Radiation Oncology Training
Laughlin, Brady, Gergelis, Kimberly R.

Applied Radiation Oncology | June 16, 2023 | Volume: No volume available | Issue: No issue available | Pages: 48-48

10.37549/aro1308 Get It

Using US Twinkling Artifact to Identify Breast Biopsy Markers: Brief Report
Lee, Christine U. , Moldoveanu, Dan , Urban, Matthew W. , Hesley, Gina K. , Hesley, Gina , Piltin, Mara A. , Urban, Matthew W

Radiology: Imaging Cancer | June 16, 2023 | Volume: 5 | Issue: 4 | Pages: No page available

10.1148/rycan.220168 | PMID 37326508 Get It

Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy
Chau, Harrison S., Woriax, Hannah E. , Piltin, Mara A. , Ahrendt, Gretchen , Tchou, Julia , Dugan, Catherine Lu , Sheade, Jori , Carr, Michael J. , Wong, Jasmine , Son, Jennifer D. , Yang, Rachel , Chan, Theresa Y., Terando, Alicia M. , Alvarado, Michael , Ewing, Cheryl, Tonneson, Jennifer E., Tamirisa, Nina , Gould, Rebekah , Singh, Puneet , Godellas, Constantine , Larson, Kelsey E. , Chiba, Akiko , Rao, Roshni , Sauder, Candice A. M. , Postlewait, Lauren M. , Symmans, W. Fraser , Esserman, Laura J. , Group, ISPY-2 Locoregional Working, Woriax, Hannah , Piltin, Mara , Ahrendt, Gretchen , Tchou, Julia , Dugan, Catherine Lu , Sheade, Jori , Sauder, Candice , Postlewait, Lauren , Lee, Marie Catherine , Esserman, Laura J , Boughey, JC , Symmans, W Fraser , Mukhtar, Rita A. , Yu, Hongmei , Ding, Qian , Crown, Angelena , Chan, Theresa, Ewing, Cheryl A. , Group, ISPY-2 Locoregional Working

Annals of Surgery | June 16, 2023 | Volume: 278 | Issue: 3 | Pages: 320-327

10.1097/sla.0000000000005968 | PMID 37325931 Get It

Neoadjuvant chemotherapy (NAC) increases rates of successful breast-conserving surgery (BCS) in patients with breast cancer. However, some studies suggest that BCS after NAC may confer an increased risk of locoregional recurrence (LRR). We assessed LRR rates and locoregional recurrence-free survival (LRFS) in patients enrolled on I-SPY2 (NCT01042379), a prospective NAC trial for patients with clinical stage II to III, molecularly high-risk breast cancer. Cox proportional hazards models were used to evaluate associations between surgical procedure (BCS vs mastectomy) and LRFS adjusted for age, tumor receptor subtype, clinical T category, clinical nodal status, and residual cancer burden (RCB). In 1462 patients, surgical procedure was not associated with LRR or LRFS on either univariate or multivariate analysis. The unadjusted incidence of LRR was 5.4% after BCS and 7.0% after mastectomy, at a median follow-up time of 3.5 years. The strongest predictor of LRR was RCB class, with each increasing RCB class having a significantly higher hazard ratio for LRR compared with RCB 0 on multivariate analysis. Triple-negative receptor subtype was also associated with an increased risk of LRR (hazard ratio: 2.91, 95% CI: 1.8–4.6, P < 0.0001), regardless of the type of operation. In this large multi-institutional prospective trial of patients completing NAC, we found no increased risk of LRR or differences in LRFS after BCS compared with mastectomy. Tumor receptor subtype and extent of residual disease after NAC were significantly associated with recurrence. These data demonstrate that BCS can be an excellent surgical option after NAC for appropriately selected patients.
Cancer “Avatars”: Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer
Lynch, Isaac T. , Abdelrahman, Amro M. , Smoot, Rory L. , Truty, Mark J. , Fogliati, Alessandro, Smoot, Rory L , Abdelrahman, Amro M , Alva‐Ruiz, Roberto , Fogliati, Alessandro , Graham, Rondell P.

Journal of the American College of Surgeons | June 16, 2023 | Volume: 237 | Issue: 3 | Pages: 483-500

10.1097/xcs.0000000000000786 | PMID 37326316 Get It

BACKGROUND: Pancreaticobiliary (PB) cancers are a diverse group of cancers with poor prognoses and high rates of recurrence after resection. Patient-derived xenografts (PDX), created from surgical specimens, provide a reliable preclinical research platform and high-fidelity cancer model from which to study these malignancies with consistent recapitulation of their original patient tumors in vivo. However, the relationship between PDX engraftment success (growth or no growth) and patient oncologic outcomes has not been well studied. We sought to evaluate the correlation between successful PDX engraftment and survival in several PB exocrine carcinomas, including the pancreatic and biliary tract. STUDY DESIGN: In accordance with IRB and Institutional Animal Care and Use Committee protocols and with appropriate consent and approval, excess tumor tissue obtained from surgical patients was implanted into immunocompromised mice. Mice were monitored for tumor growth to determine engraftment success. PDX tumors were verified to recapitulate their tumors of origin by a hepatobiliary pathologist. Xenograft growth was correlated with clinical recurrence and overall survival data. RESULTS: A total of 384 PB xenografts were implanted. The successful engraftment rate was 41% (158/384). We found that successful PDX engraftment was highly associated with both recurrence-free survival (p < 0.001) and overall survival (p < 0.001) outcomes. Successful PDX tumor generation occurs significantly in advance of clinical recurrences in their corresponding patients (p < 0.001). CONCLUSIONS: Successful PB cancer PDX models predict recurrence and survival across tumor types and may provide critical lead time to alter patients’ surveillance or treatment plans before cancer recurrence.
Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop
Espinoza, Sara , Khosla, Sundeep , Baur, Joseph A. , Cabo, Rafael de , Musi, Nicolas , de Cabo, Rafael , Khosla, Sundeep , Baur, Joseph A , Espinoza, Sara

The Journals of Gerontology: Series A | June 16, 2023 | Volume: 78 | Issue: Supplement_1 | Pages: 53-60

10.1093/gerona/glad034 | PMID 37325957 Get It

Abstract The geroscience hypothesis posits that by targeting key hallmarks of aging we may simultaneously prevent or delay several age-related diseases and thereby increase healthspan, or life span spent free of significant disease and disability. Studies are underway to examine several possible pharmacological interventions for this purpose. As part of a National Institute on Aging workshop on the development of function-promoting therapies, scientific content experts provided literature reviews and state-of-the-field assessments for the studies of senolytics, nicotinamide adenine dinucleotide (NAD+) boosters, and metformin. Cellular senescence increases with age, and preclinical studies demonstrate that the use of senolytic drugs improves healthspan in rodents. Human studies using senolytics are in progress. NAD+ and its phosphorylated form, NADP+, play vital roles in metabolism and cellular signaling. Increasing NAD+ by supplementation with precursors including nicotinamide riboside and nicotinamide mononucleotide appears to extend healthspan in model organisms, but human studies are limited and results are mixed. Metformin is a biguanide widely used for glucose lowering, which is believed to have pleiotropic effects targeting several hallmarks of aging. Preclinical studies suggest it improves life span and healthspan, and observational studies suggest benefits for the prevention of several age-related diseases. Clinical trials are underway to examine metformin for healthspan and frailty prevention. Preclinical and emerging clinical studies suggest there is potential to improve healthspan through the use of pharmacologic agents reviewed. However, much further research is needed to demonstrate benefits and general safety for wider use, the appropriate target populations, and longer-term outcomes.
Tibial Spine Fractures in the Child and Adolescent Athlete: A Systematic Review and Meta-analysis
Orellana, Kevin J., Houlihan, Nathan, Carter, Michael V. , Baldwin, Keith D. , Stevens, Alexandra C. , Ellis, Henry B. , Kushare, Indranil , Johnson, B. Lamar , Kerrigan, Alicia , Kirby, Julia, McKay, Scott , Milbrandt, Todd A. , Mistovich, R. Justin , Schmale, Gregory A. , Traver, Jessica L. , Ganley, Theodore J. , Carter, Michael V., Baghdadi, Soroush , Cruz, Aristides I. , Green, Daniel W , MacDonald, James Patrick , Parikh, Shital N. , Patel, Neeraj M. , Yen, Yi‐Meng

The American Journal of Sports Medicine | June 16, 2023 | Volume: 52 | Issue: 5 | Pages: 1357-1366

10.1177/03635465231175674 | PMID 37326248 Get It

Background: Tibial spine fractures (TSFs) are uncommon injuries that may result in substantial morbidity in children. A variety of open and arthroscopic techniques are used to treat these fractures, but no single standardized operative method has been identified. Purpose: To systematically review the literature on pediatric TSFs to determine the current treatment approaches, outcomes, and complications. Study Design: Meta-analysis; Level of evidence, 4. Methods: A systematic review of the literature was performed in accordance with the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) guidelines using PubMed, Embase, and Cochrane databases. Studies evaluating treatment and outcomes of patients <18 years old were included. Patient demographic characteristics, fracture characteristics, treatments, and outcomes were abstracted. Descriptive statistics were used to summarize categorical and quantitative variables, and a meta-analytic technique was used to compare observational studies with sufficient data. Results: A total of 47 studies were included, totaling 1922 TSFs in patients (66.4% male) with a mean age of 12 years (range, 3-18 years). The operative approach was open reduction and internal fixation in 291 cases and arthroscopic reduction and internal fixation in 1236 cases; screw fixation was used in 411 cases and suture fixation, in 586 cases. A total of 13 nonunions were reported, occurring most frequently in Meyers and McKeever type III fractures (n = 6) and in fractures that were treated nonoperatively (n = 10). Arthrofibrosis rates were reported in 33 studies (n = 1700), and arthrofibrosis was present in 190 patients (11.2%). Range of motion loss occurred significantly more frequently in patients with type III and IV fractures ( P < .001), and secondary anterior cruciate ligament (ACL) injury occurred most frequently in patients with type I and II fractures ( P = .008). No statistically significant differences were found with regard to rates of nonunion, arthrofibrosis, range of motion loss, laxity, or secondary ACL injury between fixation methods (screw vs suture). Conclusion: Despite variation in TSF treatment, good overall outcomes have been reported with low complication rates in both open and arthroscopic treatment and with both screw and suture fixation. Arthrofibrosis remains a concern after surgical treatment for TSF, but no significant difference in incidence was found between the analysis groups. Larger studies are necessary to compare outcomes and form a consensus on how to treat and manage patients with TSFs.